Skip to content
TrackPodcasts
businessJun 29, 202035:11pending

Pricing Remdesivir; Instagram Co-Founder’s Covid Tracking Data

Squawk Pod

About this episode

Drug maker Gilead has announced pricing for its Covid treatment Remdesivir, but it’s more expensive in the U.S. than in other developed countries. Gilead CEO Daniel O’Day explains the health care factors in setting the drug’s cost. Instagram co-founder Kevin Systrom launched the Covid-19 case tracker website RT.live in April. The site breaks down infection cases and potential for continued spread state by state. Systrom explains how RT.live is a tool for Americans to stay informed about their communities, and former FDA Commissioner Dr. Scott Gottlieb shares how the site’s data can help U.S. states stay safe. Plus, another “friend” bites the dust. Companies continue to pull their advertising spending from Facebook as the #StopHateforProfit campaign gains momentum. 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Get every episode summarized

Each time Squawk Pod publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Pricing Remdesivir; Instagram Co-Founder’s Covid Tracking Data

Squawk Pod

0:00
35:11

More episodes

More from Squawk Pod

View all episodes →